We are proud to announce that SuperEllipse and Secuped have received the Crossroads funding from Interreg to advance the development of our preventive health technologies.

The awarded subsidy supports our joint effort to move from a Proof of Principle prototype to a demonstrator prototype for home monitoring of diabetic feet. This next step will focus on improving ease of use and addressing key technical challenges, followed by validation in a realistic test environment (from TRL 4 to TRL 6).

By strengthening early detection and prevention, this project contributes to reducing the growing pressure on healthcare systems and avoiding costly complications for people at risk of diabetic foot ulcers.

We would like to thank Interreg and their team for their trust and valuable support in realising this important step toward smarter preventive care. 

For more information (in Dutch), please check:

https://interregvlaned.eu/nieuws/een-voetscan-die-amputaties-helpt-voorkomen

Met steun vanuit het Europees Fonds voor Regionale Ontwikkeling.